APA (7th ed.) Citation

White, C., Wardill, H., Paul, C., Price, T., Karapetis, C., Nalder, M., . . . Scott, R. J. (2024). DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia. BMC Cancer, 24(1), . https://doi.org/10.1186/s12885-024-13122-8

Chicago Style (17th ed.) Citation

White, Cassandra, et al. "DPYD Genotype-guided Dose Personalisation for Fluoropyrimidine-based Chemotherapy Prescribing in Solid Organ Cancer Patients in Australia." BMC Cancer 24, no. 1 (2024). https://doi.org/10.1186/s12885-024-13122-8.

MLA (9th ed.) Citation

White, Cassandra, et al. "DPYD Genotype-guided Dose Personalisation for Fluoropyrimidine-based Chemotherapy Prescribing in Solid Organ Cancer Patients in Australia." BMC Cancer, vol. 24, no. 1, 2024, https://doi.org/10.1186/s12885-024-13122-8.